Skip to main content

Posts

Featured

COVID-19: Changing the Face of Cancer Care

The healthcare systems have shifted their attention to COVID-19. Unfortunately, patients with chronic conditions such as cancer have had to make tough decisions. MD, Chief medical officer and executive president of ASCO(American Society of Clinical Oncology) said, “ Patients undergoing cancer treatment have had to make difficult choices to interrupt or modify their cancer treatment to decrease their risk of COVID-19 but thereby increase their risk of cancer progression or to continue their cancer treatment, risking a greater likelihood of COVID-19 disease or complications.” Healthy individuals have had to postpone their screening, and newly diagnosed patients have not yet started their treatment. Clinical trials for new therapies have slowed down due to the pandemic.   When COVID-19 was first reported, reports indicated that people with a weak immunity had the worse COVID-19 outcomes. However, as researchers compiled more information and results, there were varying trends. Fo

Latest Posts

High Colorectal Cancer Rates in Men Linked to Androgen Levels

Men and Women Can Feel Different Side Effects after Chemotherapy

Chronic Obstructive Pulmonary Disease can Increase Lung Cancer Risk in Non-Smokers

Using High Dose Brachytherapy to Treat Skin Cancer

A New Colorectal Cancer Vaccine Can Benefit Patients with Pancreatic Cancer Too

3 Ways to Detect and Prevent Breast Cancer

Genetic Testing Can Help to Manage Cancer Risk

How Does Targeted Therapy Treat Cancer?